We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

37 hedge funds and large institutions have $19.7M invested in Faeth Therapeutics in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.58% → 0.56% (-0.02%)

12% less funds holding

Funds holding: 42 → 37 (-5)

31% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 13

47% less capital invested

Capital invested by funds: $37.1M → $19.7M (-$17.3M)

Holders
37
Holders Change
-5
Holders Change %
-11.9%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
8
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.51M
2
State Street
State Street
Massachusetts
+$316K
3
Morgan Stanley
Morgan Stanley
New York
+$250K
4
Two Sigma Investments
Two Sigma Investments
New York
+$215K
5
UBS Group
UBS Group
Switzerland
+$160K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.3M
2
Millennium Management
Millennium Management
New York
-$1.28M
3
MCM
Moore Capital Management
New York
-$519K
4
AA
ALPS Advisors
Colorado
-$394K
5
MCCP
Mission Creek Capital Partners
California
-$345K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$51K +$65.1K +436 +14,533%
Citigroup
27
Citigroup
New York
$37K +$30K +201 +168%
New York State Common Retirement Fund
28
New York State Common Retirement Fund
New York
$32K +$598 +4 +1%
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$26K +$14.3K +96 +79%
TRCT
30
Tower Research Capital (TRC)
New York
$21K +$21.2K +142 +364%
Legal & General Group
31
Legal & General Group
United Kingdom
$10K – – –
AIP
32
Ameritas Investment Partners
Nebraska
$9K – – –
BCV
33
Banque Cantonale Vaudoise
Switzerland
$5K +$4.48K +30 +200%
IRAG
34
Investment Research & Advisory Group
Georgia
$4K – – –
PHK
35
Point72 Hong Kong
Hong Kong
$4K +$5.83K +39 New
SCA
36
Snowden Capital Advisors
New York
$1K +$1.49K +10 New
Citadel Advisors
37
Citadel Advisors
Florida
– -$1.3M -6,163 Closed
MCM
38
Moore Capital Management
New York
– -$519K -2,467 Closed
AA
39
ALPS Advisors
Colorado
– -$394K -1,874 Closed
MCCP
40
Mission Creek Capital Partners
California
– -$345K -1,639 Closed
TCM
41
Tao Capital Management
California
– -$345K -1,639 Closed
PVI
42
Pura Vida Investments
New York
– -$238K -1,130 Closed
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$142K -674 Closed
SG Americas Securities
44
SG Americas Securities
New York
– -$133K -631 Closed
Jane Street
45
Jane Street
New York
– -$113K -539 Closed
S
46
SignatureFD
Georgia
– -$1K -7 Closed
US Bancorp
47
US Bancorp
Minnesota
– -$1K -5 Closed
PA
48
Parallel Advisors
California
– -$1K -3 Closed
EI
49
Ellevest Inc
New York
– +$149 +1 New
1
2

FTH Hedge Fund Activity: Q4 2021 in Review

37 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q4 2021, worth a combined $19.7M — down 47% from $37.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of FTH and 9 opened new positions — a net loss of 4 holders — while 8 trimmed existing stakes and 15 added.

The largest buyer was BlackRock, adding an estimated $1.51M. The largest seller was Citadel Advisors, exiting entirely with an estimated $1.3M sold.

  • 37 institutional investors held Faeth Therapeutics (FTH) as of Q4 2021, down from 42 in Q3 2021.
  • Funds reported $19.7M of Faeth Therapeutics stock for Q4 2021, down 47% quarter-over-quarter.
  • 9 funds opened new Faeth Therapeutics positions in Q4 2021 and 13 closed out, a net change of -4 holders.
  • The largest Faeth Therapeutics buyer in Q4 2021 was BlackRock, an estimated $1.51M added.
  • The largest Faeth Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $1.3M sold.

Based on aggregated 13F filings for Q4 2021.